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Aminolysis of N-acetylmuramic acid (MurNAc) lactones,
carrying different HO-6 substituents, with amino acid or peptide
esters as nucleophiles was studied. The reaction of the protected
(1-+ 6) linked GlcNAc-MurNAc lactone I with r.-alanine methyl
ester, performed in dioxane in the presence of imidazole and
tetra-n-hexylammonium benzoate (THAB), gives amoderate (42%)
yield of the disaccharide-amide VI. This was converted into the
4-acetate VII, also prepared by coupling of the ~-(1-+6)-linked
disaccharide acid V with Ala-OMe. Benzyl «-glycosides of HO-6
acetylated, tritylated and benzylated MurNAc lactones (IX, XI,
XVIII) were used in aminolysis reactions with Ala-OMe and
Ala-Gly-OBzl under various conditions. It is shown that the
presence of imidazole and THAB, as well as the nature of the
solvent, have a significant influence on the formation of the re-
spective muramoylamides X, XII, XIII and XIX, resp.; conditions
were elaborated to obtain these compounds in satisfactory (60-
-800/0) yields, Additional evidence that the lactone ring-opening
proceeds without epimerisation at C-4 is provided.
INTRonUCTION
Bacterial cell-wall peptidoglycan consists of polysaccharide chains joined
to short peptides of characteristic amino acid compositiori'. The basic struc-
ture of the glycan strands of the biopolymer is made up of alternating
P-(1~4)-linked pyranosides of 2-acetamido-2-deoxY-D-glucose (GlcNAc) and
2-acetamido-3-0-[(R)-1-carboxyethyl]-2-deoxy-n-glucopyrano se (N-acetylmur-
amic acid, MurNAc); the peptide units, attached through the amide bonds
to the MurNAc carboxyl groups, are cross-linked in different directions".
Peptidoglycan polymers have been known for a long time as effective stimu-
lators of the immune response", Since N-acetylmuramoyl-L-alanyl-D-isogluta-
mine (MDP) was shown! to be the smallest structure possessing immunomodu-
lating activities, many MDP derivati ves and analogues have been synthesised
with the objective of developing a new class of organic compounds usable
for immunotherapeutic application",
+ Present address : PLIVA, Pharmaceutical and Chemical Works, Zagreb, Yu-
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Earlier work in this laboratory has shown" that penicillin treatment of
a Brevi.bacterium divaricatum mutant causes immediate and massive secretion
of non-cross-linked peptidoglycan fragments into the culture medium. From
the excreted linear polymer, the repeating unit [-GlcNAc-,8-(1-+4)-MurNAc-
-pentapeptide] was isolated and characteriseds'". This unit enhances the
immune response and interferes with some mltogensv ".
N-Acetylmuramic acid and its derivatives with HO-4 group unsubstituted
easily undergo intramolecular esterification to give bicyclic lactones'<!". The
latter compounds have often been recognised as byproducts in reactions in-
volving MurNAc derivatives. However, in most cases, they were subjected,
without isolation, to hydrolysis in alkaline methanolic solutions at elevated
temperature. Recently, we have shown-" that methanolysis of glycosides of
MurNAc lactones is catalysed, at room temperature, by small amounts of
silica gel to give, exclusively, the corresponding HO-4 free methyl esters with
retention of the D-gluco configuration. Analogously, methanolysis of the fully
protected ,8-(1-+6)-linked disaccharide lactone I, prepared bycondensation of
the oxazoline derivative of 2-acetamido-2-deoxY-D-glucopyranose and the
HO-6 free. MurNAc lactone VIlI, afforded the ,8-(1-+6)-disaccharide methyl
ester II as the exclusive product.
The amide bond formation in the syntheses of different MDP-related
compounds has been achieved4,17-20 by methods used in peptide chemistry, i. e.
by coupling the sugar and peptide components in the presence of a carboxyl
activating and/or condensing agent. Our preliminary experiments have shown-"
that, in the presence of imidazole as catalyst, the MurNAc lactones undergo
aminolysis with amino acid or peptide esters as nucleophiles to give the
N-acetylmuramoylamide derivatives. In order to explore further the potential
of this reaction as a synthetic route to compounds structurally related to
peptidoglycan fragments, we have investigated the factors that influence the
susceptibility of the MurNAc lactone carbonyl group toward aminolysis. Some
new, suitably protected MurNAc derivatives were synthesised for this purpose.
RESULTS AND DISCUSSION
Selective hydrolysis of the methyl ester group of the HO-4 unsubstituted
,8-(1-+6)-linked disaccharide II, obtainable'" by either direct synthesis or by
silica gel-catalysed methanolysis of the disaccharide lactone I, yielded the
corresponding free acid III which was isolated and characterised. Convention al
acetylation of III with acetic anhydride-pyridine led to cyclisation of the
MurNAc moiety to give the disaccharide lactone I as the sole product. An
attempt to couple the disaccharide acid III with L-alanine methyl ester, by
using dicyclohexylcarbodiimide and N-hydrosuccinimide (DCe, HOSu) as
the activating agents, failed because the majority of III lactonised during the
activation step into I, thus providing a further example of the ease with
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Methyl ester hydrolysis of the 4-0-acetyl derivative of II (IV16) led to
the fully protected (1-+6)-linked disaccharide acid V which, on condensation
with L-alanine methyl ester in the presence of DCC and HOSu as activating
agents, furnished the peracetylated 2-acetamido-2-deoxY-D-glucopyranosyl-,6-
-(1-+6)-N-acetylmuramoyl-L-alanine methyl ester derivative VII. The lH-NMR
spectrum (CDC13) of VII was in agreement with the structure expected; the
signals assigned to H-3',4' and H-4 of the GlcNAc and MurNAc moiety,
respectively, appeared at a lower field than all other ring proton signals and
with coupling constants (,...,9 Hz) indicative of the D-gluco configuration of
both monosaccharide units.
The alternative synthesis of VII via aminolysis of the disaccharide
lactone I, was first performed by reacting I with L-alanine methyl ester in
r
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dioxane, in the presence of imidazole (5 equivs). Under these conditions, the
reaction was sluggish and, after one week at room temperature, ,...,25010
of the HO-4 unsubstituted disaccharide-amide VI was isolated from the react-
ion mixture. Tetra- n-hexylammonium benzoate (THAB) has been claimed'"
to be an efficient catalyst in the aminolysis of p-nitrophenylacetate by imi-
dazole in toluene at 25 DC; the authors proposed that THAB effects catalysis
by removing a proton from the cationic imidazole component of the tetra-
hedral intermediate, thus permitting collapse of the intermediate to an un-
protonated acylimidazole product. When THAB (0.5 equiv), was added to the
above aminolysis mixture, a notable (monitoring of the reaction by TLC)
enhancement of the rate of formation of VI took place, and a 42010 yield of
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afforded the fully protected disaccharide-amide derivative with physical con-
stants including IH-NMR data identical to those of VII prepared by the
active ester method from the disaccharide acid V.
In order to investigate the conditions which would make the above
reaction more effective for the synthesis of different muramoylamides, we
turned to simpler members of the series, i. e. the benzyl a-glycosides of the
HO-6 acetylated'" and -tr'itylated'v'" lactones IX and XI, respectively, and
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studied their aminolysis by t.-alanlne methyl ester and L-alanyl-glyci:ae benzyl
ester under various conditions.
Typical results of the reaction of the lactone IX with r.-alanyl-glycine
benzyl ester are summarised in Table I. From the data presented, it is evident
that the presenee of THAB, as well as the nature of the solvent have signi-
ficant effects on the extent of the formation of the muramoyldipeptide ester
X; treatment of IX with 1.5 equiv of the dipeptide ester, 5 equivs of imidazole
and 1 equiv of THAB in dry tetrahydrofurane (Expt. No 5) resulted in the
clean formation of X in 72% yield. The fact that in the presenee of THAB,
but without imidazole, the reaction failed completely, agrees well with the
proposed'" catalytic role of the former in the aminolysis of esters by imidazole
in aprotic solvents. In the present case, apparently, the formed N-acylimi-
dazole participates22-24 in the transfer of the muramoyl acyl group to the
nucleophile.
TABLE I
Formaiton of N-Acetylmuramoyldipeptide Ester Derivative X in the Reaction of
HO-6 Acetylated MurNAc Lactone IX with L-Ala-Gly-OBzl Under Various
Conditions
Reaction Conditions'
Expt. Molar ratio to IX Yield of x-No. Time
Imidazole
Solvent days %THAB
1 2 dioxane 2 15
2 2 0.5 dioxane 6 37
3 5 0.5 dioxane 7 44
4 5 1.0 dioxane 3 57
5 5 1.0 THF 3 72
a Each experiment was performed with 0.25 mmol (102 mg) of IX and 0.37 mmol
(1.5 molar excess) of H-L-Ala-Gly-OBzl, libera ted from the TFA salt, in a total
of 12 ml of the solvent indicated at room tempo
b Refers to the isolated, chromatographically homogeneous product, except in
Expt. No. 1.
Evidence of a marked effect on the extent of aminolysis of the nature
of the substituent was obtained in experiments with the HO-6 tritylated
lactone XI. While the 6-0-acetyl lactone IX underwent aminolysis with
r.-alanine methyl ester in dioxane at room temperature in the presenee of
imidazole (5 equivs) to give a 52% yield of the corresponding muramoylamide",
the lactone XI was practically inert under these conditions, and only trace
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amounts ( 10010)of the expected product XII were revealed by TLC. The
difference in reactivity between the two lactones can be ascribed mainly
to steric factors; the access of the nucleophile's amino group to the lactone
carbonyl of XI should be much more sterically hindered due to the presence
of the bulky trityl group. However, addition of either THAB or tetra-n-butyl-
ammonium benzoate (TBAB) accelerated the reaction to give XII in high
(76-79010) yields; no significant difference between the efficiency of the two
tetraalkylammonium benzoate salts was observed. It is interesting that amino-
lysis of XI by L-alanyl-glycine benzyl ester was greatly influenced by the
solvent used; under otherwise identical experimental conditions, the reactions
performed in dioxane and tetrahydrofurane afforded the muramoyl-dipeptide
ester XIII in yields of 41 and 60010,respectively.
Acetylation of XIII afforded the 4-acetate derivative XIV; its lH-NlVIR
spectrum (Py-đj) revealed the H-4 proton at position (o 5.20) and with vicinal
coupling constants (J4,3 9.03, J4,5 9.52 Hz) fully consistent with the D-gLuco
configuration, thus providing evidence that under the conditions elaborated
the lactone ring-opening proceeds without epimerisation at C-4.
In order to prepare a HO-6 benzylated and HO-4 unsubstituted N-acetyl-
muramic acid derivative, suitable for glycosylation at 0-4, we undertook the
reductive ring opening of the 4,6-0-benzylidene acetal of benzyl a-glycoside
of N-acetylmuramic acid methyl ester25 (XV) with sodium cyanoborohydride-
-hydrogen chloride. This reaction, introduced in carbohydrate chemistry by
Garegg26,27 proceeds with high regioselectivity to give the benzyl group at
0-6 and is compatible with the presence of ester and acetamido groups in
the molecule. However, a direct application of the procedure to XV resulted
in a very low yield of the desired HO-6 benzylated derivative XVI and a
high recovery of the starting XY. Nevertheless, when the reaction was per-
formed with a large excess (12 equivs) of sodium cyanoborchydride, which
was added gradually to the reaction mixture over a prolonged ( 24 h) time,
XVI was obtained in excellent (> 85010)yields. lH-NlVIR data of the product
and its acetylated derivative XVII provided evidence for the expected struc-
ture: the H-4 signal in the spectrum (CDC13) of XVII resonateda.t the lowest
field of other non-anomeric protons, thus indicating that the O-acetyl group
was located at position 4.
Selective hydrolysis of the methyl ester group of XVI afforded a free
-acid which was directly subjected to DCC condensation to' give the HO-6
benzylated lactone XVIII (72010overall yield). The same compound could be
obtained, in a considerably lower (38010)yield, by treating the HO-6 unsub-
stituted lactone VIlI with benzyl bromide in the presence of silver carbonate.
Dissolution of XVIII in methanol, in the presence of a catalytic amount of
-silica gel, led to opening of the lactone ring to give asingle product, indi-
r
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stinguishable from XVI obtained by regioselective ring opening of XV; acetyl-
ation of the methanolysis product afforded XVII.
Aminolysis of the lactone XVIII, having a rather bulky substituent at
0-6, by L-alanine methyl ester proceeded smoothly, when performed in tetra-
hydrofurane and in the presence of imidazole and THAB; the HO-6 benzyl-
ated muramoylamide derivative XIX was isolated in a 750/0 yield. With dioxane
as solvent, the reaction proceeded at a slower rate, whereas in the absence
of THAB, only a very low amount (,...,15%) of the expected product was
formed within several days. The structure of XIX was confirmed by eon-
version into the 4-0-acetyl derivative XX whose lH-NMR spectrum (CDCh)
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Chort 3
To conclude, the results obtained with different lactones of N-acetyl-
muramic acid derivatives suggest that the aminolysis approach is a promising
synthetic route to several peptidoglycan-related structures.
General
EXPERIMENTAL
Melting points were determined in capillaries and are not corrected. Solvents
were removed under reduced pressure at < 45DC. Column chromatography was
performed on Silica Gel (Merck, 0.02-0.2 mm) and TLC on Silica Gel 60 (Merck);
detection was effected by charring with sulphuric acid, or with the chlorine-iodine
I I
f
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reagent for peptides. The solvents used were: A ethyl acetate-ethanol-water (5:2:1);
B chloroform-ethyl acetate-acetone (3:1:3); C ethyl acetate-acetone (4:1); D chloro-
form-acetone (proportions are given in the text); E chloroform-ethyl acetate (1:1);
F chloroform-acetone-light petroleum (3:2:2). Optical rotations were determined
for 1010solutions in chloroform, if not stated otherwise. 1H-NMR spectra (100 MHz,
internal Me4Si) were record ed with a Jeol JNM FX-100 spectrometer for solutions
in CDCI3, if not stated otherwise.
Benzyl 2-acetamido-6-0-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-{J-D-gluco-
pyranosyl)-3-0-[(R)-1-carboxyethyl]-2-deoxy-a-D-glucopyranoside (III)
To a stirred solution of the HO-4 unsubstituted disaccharide methyl ester
II1G(109.5 mg, 0.15 mmol) in 1,4-dioxane (5 ml) 0.1 M aq. KOH (1.98 ml) was added
under cooling (ice-water bath); the progress of the reaction was monitor ed by
TLC in solvent A. After -70 min, the solution was neutralised with Amberlite
IR 120B (Ir), the residue was filtered off and washed with methanol, and the
combined filtrate and washings were evaporated. The resulting glass was passed
through a column of silica gel with solvent A to give chromatographically homo-
geneous III (90 mg, 83.8010) as a white solid. Crystallisation from acetone-diisopropyl
ether afforded the analytical sample, m. p. 242-244°C, [ah + 58.2° (MeOH). 1H_
-NMR data (Py-ds): c5 9.44 (d, J 8.5 Hz, NH), 9.27 (bs NH), 2.16, 2.04, 2.01 (3 s,
15 H, 2 AcN, 3 AcO), 1.68 (d, J 7.08 Hz, MeCH).
AnaI. C32H44N2016(712.69) calc'd.: C 53.92; H.6.22; N 3.93010
found: C 53.75; H 6.54; N 4.040/0
A sample (25 mg) of III was treated with acetic anhydride-pyridine (1:1, 2 ml)
overnight at room tempo Conventional work-up and crystallisation of the residue
from acetone-light petroleum gave crystals (18 mg, 74010)with m. p., IR and NMR
spectra indistinguishable from those of an authentic sample of the disaccharide
lactone IlG.
A solution of III (40 mg, 0.056 mmol) in dry tetrahydrofurane (THF, 3 ml)
was stirred with N-hydroxysuccinimide (HOSu, 10 mg, 0.09 mmol) and N,N'-dicyclo-
hexylcarbodiimide (DCC, 18 mg, 0.09 mmol) for 5 h at room tempo i.-Alanine methyl
ester [libera ted from 15 mg (0.11 mmol) of the HCI salt with Et3NJ was added, and
the mixture was stirred overnight. The residue left after removal of the solvent
was chromatographed on a silica gel column with solvent B, and the appropriate
fractions were rechromatographed on a second column with solvent C to give a
solid (25 mg, 64010),indistinguishable (m. p., IR, NMR) from an authentic sample
of the lactone I.
Benzyl-2-acetamido-4-0-acetyl-6-0-(2-acetamido-3,4,6-tri-O~acetyl-2-deoxy-
-{J-D-glucopyranosy l )-3-O-[(R)-l-carb oxyeth y l] -2-deoxy-a- D-glucopyranoside (V)
A solution of the fully protected disaccharide methyl ester IV16 (120 mg, 0.156
mmol) in dioxane was treated with 0.1 M KOH (2.42 ml) under cooling for - 60
min and further processed as described for III to give the crude acid V (112 mg,
95010) as a white solid that was thoroughly dried and directly used in the next
step. 1H-NMR data (Py-ds): s 9.43 (bs, NH), 9.25 (d, J 8.8 Hz, NH), 2.15, 2.14, 2.06,
2.01 (4 s, 18 H, 2 AcN, 4 AcO), 1.63 (d, J 7.08 Hz, MeCH); DMSO-d6: s 7.33 (5 H,
Ph), 2.014, 2.010, 1.967, 1.904, 1.811, 1.727 (6 s, 18 H, 2 AcN, 4 AcO), 1.48 (d, J 7 Hz,
MeCH).
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N-{2-O-[B enzy L 2-acetamido-6-0-(2-acetamido-3 ,4,6- tri-O-acetyL-2-deoxy-
-{J-D-gLucopyranosyL)-4-0-acetyL-2,3-dideoxy-a-D-gLucopymnoside-3-yL]-
-(R)-LactoyL}-L-aLanine methyL ester (VII)
(a) By condensation. - To a stirred solution of V (55 mg, 0.073 mmol) in dry
THF (4 ml) HOSu (17.5 mg, 0.15 mmol) and DCC (31 mg, 0.15 mmol) were added
at room tempo and, after 5 h, L-alanine methyl ester [liberated from 21 mg (0.15
mmol) of the HCI salt with Et3N] in THF (1 ml). The mixture was stirred for
additional 24 h, the solvent was evaporated, and the residue was chromatographed
on asilica gel column with solvent B. Concentration of the appropriate fractions
gave crude VII (37 mg, 60%) which was crystallised from acetone-Iight petroleum
to give the pure product (23 mg, 37.5010calc'd. on IV), m. p. 272-274°C. lH-NMR
data: ~ 7.35 (s, Ph), 6.90 (d, J 6.6 Hz, NH), 6.06 (d, J 8.55 Hz, NH), 5.85 (d, J 9.28
Hz, NH), 5.14, 5.07, 5.04 (3 overlapped t, 3 H, J ~9 Hz, H-3',4',4), 4.93 (d, J1.2 3.66
Hz, H-1), 3.70 (s, C02Me), 2.117, 2.087, 2.027, 2.018, 1.972, 1.871 (6 s, 18 H, 2 AcN,
4 AcO), 1.44 (d, J 7.3 Hz, MeCH), 1.32 (d, J 6.8 Hz, MeCH).
AnaL C3SHssNsOlS(839.83) calc'd.: C 54.34; H 6.36; N 5.00010
found: C 54.58; H 6.51; N 5.15010
(b) By aminolysis. - To the disaccharide lactone I (69.5 mg, 0.1 mmol) . in
1,4-dioxane (10 ml) were added imidazole (34 mg, 0.5 mmole), L-alanine methyl
ester [liberated from the HCI salt (35 mg, 0.25 mmol) with N-methylmorpho1ine]
and tetra-n-hexylammonium benzoate (THAB, 24 mg, 0.05 mmol, prepared according
lit.21•28and dried at 80 °C/O.OI mm for 9h). The reaction mixture was kept under
anhydrous conditions at room temp., with occasional stirring, for one week. After
removal of the solvent, the residue was chromatographed on silica gel with solvent
D (1:3) to give homogenous VI (32 mg, 40010)which crystallised from diisopropyl
ether-acetone-light petroleum, m. p. 234-236 o.
Treatment of the above compound with AC20-Py (1:1, 2 ml) at room tempo
overnight, followed by conventional work-np, left a residue which was crystallised
from acetone-light petroleum to give crystals (24.8 mg, 74010),m. p. 272-274 aC
which was indistinguishable (mixed m. p., lH-NMR spectrum) from VII obtained
by route (a). (Found: C 54.24; H 6.60; N 5.10010).
N -[2 -O-(Benzy L 2 -acetamido-6-0-acety L-2,3 -dideoxy-a- D-g Lucopymnoside-3 -y L)-
-(R)-LactoyL]-L-aLanyLgLycine benzyL ester (X)
A solution of the 6-0-acetyl-Iactone IX14•16 (102 mg, 0.25 mmol) and imidazole
(85 mg, 1.25 mmol) in dry THF (10 ml) was stirred at room tempo for 30 min;
a solution of dry L-alanyl glycine benz yl ester trifluoroacetate [prepared from
Boc-Ala-Gly-OBzl (124 mg, 0.37 mmol)] in THF (1 ml) was treated with N-methyl-
morpholine (41 ul) and then added to the reaction mixture, followed by THAB
(119 mg, 0.25 mmol) in THF (1 ml). The reaction was kept at room temp., with
occasional stirring, for 3 days (monitoring of the reaction by TLC in solvent D)
and then concentrated. The residue was passed through a column of silica gel with
solvent D (1 : 2.5) to give chromatographically homogeneous X (116 mg, 72%, RF 0.69).
Crystallisation from diisopropylether-acetone-light petroleum deposited crystals,
m. p. 189-1900, [aJo + 600• lH-NMR data: o 7.33 (10 H, 2 Ph), 7.10 (d, J 7.9 Hz, NH
of MurNAc), 6.91 (bs, NH of Gly), 6.30 (d, J 8.5 Hz, NH of Ala), 5.14 (s, 2 H,
C02CH2Ph), 4. 92 (d, J1.2 3.51 Hz, H-1), 3.99 (d, 2 H, J 5.57 Hz, collapsed to s on
deuteration, CH2 of Gly), 2.11 (s, 4 H, AcO + HO-4; after deuteration: 3 H), 1.91
(s, AcN), 1.41 and 1.39 (2 d, J 7.32 and 6.44 Hz, 2 MeCH).
Anal. C32H41N3011(643.67) calc'd.: C 59.71; H 6.42; N 6.53%
found: C 59.52; H 6.28; N 6.62010
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N-[2-O-(B enzy l 2-acetamido-2 ,3-dideoxy-6-0- trity l-a- D-9lucopyranoside-3 -y l)-
-(R)-lactoyl]-L-alanine methyl ester (XII)
To a solution of 6-0-trityl-lactone XI14.16(61 mg, 0.1 mmol) in dioxane (7 ml)
were added L-alanine methyl ester [libera ted from HCl salt (28 mg, 0.2 mmol) with
N-methylmorpholine], imidazole (34 mg, 0.5 mmol) and tetra-n-butylammonium
benzoate'" (TBAB, 182 mg, 0.5 mrnol) in a total of 8 ml of dioxane. After 5 days
at room temperature, the solvent was evaporated, and the residue passed through
a silica gel column with solvent E to give chromatographically pure XII (56 mg,
790/0)which crystallised from acetone-light petroleum, m. p. 217-218°C, [ah + 74°.
lH-NMR data: 8 7.54-7.25 (m, 20 H, 4 Ph), 6.92 (d, J 7.2 Hz, NH of Ala), 6.18
(d, J 9 Hz, NH of MurNAc), 4.93 (d, J1.2 3.42 Hz, H-1), 3.69 (s, C02Me), 3.41-2.33
(m, 2 H, H-6,6'), 1.92 (s, 4 H, AcN + HO-4; after deuteration: 3 H), 1. 43 and 1.39
(2 d, J 7.08 and 6.84 Hz, 2 MeCH).
An aL C41H46N209(710.79) calc'd.: C 69.28; H 6.52; N 3.94%
found: C 69.38; H 6.79; N 4.15%
N-[2-O-(B enzy l 2-acetamido-2 ,3-dideoxy-6-0- t?'ity l-a- D-9lucopyranoside-3 -yl)-
-(R)-lactoyl]-L-alanylglycine benzyl ester (XIII)
6-0-Trityl-lactone XI (182 mg, 0.3 mmol) was treated with L-alanylglycine
benzyl ester [prepared from Boc-Ala-Gly-OBzl (151 mg, 0.45 mmol) via trifluoro-
acetate salt] in the presence of imidazole (102 mg, 1.5 mmol) and THAB (143 mg,
0.3 mmol) in dry THF (total 15 ml), exactly as described for X. After 3 days,
(monitoring of the reaction in solvent D by TLC), the solvent was removed, the
residue passed through silica gel with solvent E, and the chromatographically
homogeneous XIII (152 mg, 60%) crystallised from acetone-Iight petroleum, m. p.
178-179°C, [ah + 50°. lH-NMR data: 8 7.49-7.23 (m, 25 H, 5 Ph), 7.03-6.85 (m,
2 H, NH of Gly and MurNAc), 6.16 (d, J 7.9 Hz, NH of Ala), 5.11 (s, 2 H, C02CH2Ph),
4.92 (d, J1.2 3.22 Hz, H-1), 3.97 (d, 2 H, J 5.27 Hz, CH2 of Gly) 3.42-3.31 (m, 2 H,
H-6,6'), 1. 92 (s, 4 H, AcN + HO-4), 1.42 and 1.37 (2 d, J 7.03 and 6.44 Hz, 2 MeCH).
AnaL C49H53N3010(843.94) calc'd.: C 69.73; H 6.33; N 4.98%
found: C 69.76; H 6.39; N 5.20%
N-[2-O-(Benzyl 2-acetamido-4-0-acetyl-2 ,3-dideoxy-6-0- t?'ityl-a- D-gluco-
pymnoside-3-yl)-(R)-lactoyl]-L-alanylglycine benzyl ester (XIV)
Treatment of XIII (118 mg, 0.14 mmol) with AC20-Py (1:2, 3 ml) for -20 hrs,
followed by conventional work-np and drying of the CHC13 extract over anhydrous
Na2S04, gave, after removal of the solvent, a glassy mass; trituration with light
petroleum yielded XIV (97 mg, 78.2°/0) as an amorphous powder, m. p. 128-1300C
(softening at 800C), [ah + 60°. lH-NMR data: 8 7.5-7.2 (m, 25 H, 5 Ph), 7.0-6.8
(m, 2 H, 2 NH), 5. 97 (d, J 9.5 Hz, NH), 5.13 (s, C02CH2Ph), 4.97 (d, J1.2 2.64 Hz,
H-1), 4.85 and 4.54 (2 d, 2 H, s.: 11.4 Hz, OCH2Ph), 4.03 (d, J 5.27 Hz, CH2 of Gly) ,
3.18-3.05 (m, 2 H H-6,6'), 1.92, 1.75 (2 s, AcO, AcN), 1.45 and 1.27 (2 d, J 7.08 and
6.69 Hz, 2 MeCH); (Py-ds): c5 8.4-8.0 (m, 3 H, 3 NH), 7.7-7.2 (m, 5 Ph), 5.32 (d,
J1.2 3.66 Hz, H-1), 5.16 (s, C02CH2Ph), 5.20 (dd, J4.3 9.03, 14.5 9.52 Hz, H-4), 4.24
(d, J 5.37 Hz, CH2 of Gly), 3.41-3.35 (m, 2 H, H-6,6'), 2.04, 1.75 (2 s, AcO, AcN),
1.60 and 1.39 (2 d, J 7.08 and 6.84 Hz, 2 MeCH).
An aL C51H55N30U(885.97) calc'd.: C 69.14; H 6.26; N 4.74%
found: C 69.29; H 6.50; N 4.80%
Benzyl 2-acetamido-6-0-benzyl-2-deoxy-3-0-[(R)-1-(methoxycarbonyl)ethyl]-
-a-D-glucopyranoside (XVI)
To a stirred solution of the 4,6-0-benzylidene acetal XV (971 mg, 2 mmol)
and sodium cyanoborohydride (376 mg, 6 mmol) in dry THF (30 ml) containing
3A molecular sieves (- 3 g) hydrogen chloride in dry diethyl ether was added at
room tempo until the solution was acidic (pH paper, - 15 min). More cyanoborohy-
dride (3 X 376 mg) followed by HCl/Et20 were added after 2, 4 and 18 hrs; after a
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total reaction time of -30 h, TLC in solvent F indicated complete reaction. The
mixture was poured into ice-water, the product was extracted with chloroform, and
the combined extracts were washed successively with water, saturated sodium hydro-
gen carbonate solution and water, and kept overnight over sodium sulphate + - 0.5
g of silica gelo After removal of the solvent, the residue was purified by flash
chromatography on a column of silica gel (50 g) with solvent F to give XVI
(873 mg, 90%) as a glassy oil that crystallised on stand ing. Crystallisation from
diisopropyl ether-acetone-light petroleum afforded pure XVI, m. p. 116-117°C,
[ah + 128°. lH-NMR data: s 7.51 (bs, NH), 7.31, 7.26 (10 H, 2 Ph), 5.33 (d, J1.2
2.7 Hz, H-1), 3.73 (s, C02Me), 2.01 (s, AcN), 1.41 (d, J 7.08 Hz, MeCH).
AnaI. C2RH33NOs (487.55) calc'd.: C 64.05; H 6.82;.N 2.87%
found: C 64.21; H 6.91; N 2.86%
Benzyl 2-acetamido-4-0-acetyl-6-0-benzyl-2-deoxy-3-0-[(R)-1-(methoxy-
ca1'bonyljethyl-a-D-glucopyranoside (XVII)
A sample (93 mg, 0.18 mmol) of XVI was treated with AC20-Py (1:2, 6 ml)
at room tempo overnight, and after conventional work-np, the residue was chro-
matographed on a silica gel column with solvent E to give the 4-acetate XVII
(73 mg, 78% as a chromatographically homogeneous solid. Crystallisation from
diisopropyl ether-acetone-Iight petroleum afforded the analytical sample, m. p.
151-152°, [ah + 147°. lH-NMR data: s 7.72 (bs, IH, NH), 7.32 (10 H, 2.Ph), 5.43
(d, J1.2 2.68 Hz, H-1), 5.10 (dd, J4,3 8.79, hs 10.3 Hz, H-4), 4.71, 4.50 (2 d, Jg,m11.9
Hz, OCH2Ph), 4.51 (2 H, 6-0-CH2Ph), 4.23 (q, J 7 Hz, MeCH), 3.76 (s, C02Me),
3.50-3.45 (m, 2 H, H-6,6'), 2.02 1.95 (2 s, AcO, AcN), 1.35 (d, J 7.08 Hz, MeCH).
AnaL C2SH3SN09(529.59) calc'd.: C 63.50; H 6.66; N 2.65%
found: C 63.59; H 6.48; N 2.83%
Benzy l 2-acetamido-6-0- benzy l-2 -deoxy-3 -0-[ (R)-l-ca rboxyeth y l j -a- D-gl u-
~opyranoside 4,1'-lactone (XVIII)
- (a) From XVI. - To a stirred solution of XVI (244 mg, 0.5 mmol) in dry
dioxane (7 ml) 0.1 M aq. KOH (9 ml) was added at room temp., and after - 45
min (monitoring of the reaction by TLC in solvent A) Amberlite IR-120B (W);
the mixture was further processed as described for III to give the free acid as
glass (239 mg) which was dried over P205 and used for the next step without
purification.
A solution of the above acid in dry dioxane (5 ml) was treated with DCC
(100 mg, 0,53 mrnol) in dioxane (2 ml) for 20 hrs; dicyclohexylurea was filtered
off, the filtrate concentrated, and the residue was passed through silica gel with
solvent D (4:1) to give the lactone XVIII as a viscous oil. Crystallisation from
diisopropyl ether-acetone-Iight petroleum afforded the producet (154.4 mg, 72%)
as fluffy crystals, m. p. 160-161°C, [ah + 144°. lH-NMR data: tJ 7.33 (10 H, 2 Ph),
5.63 (d, J 9.5 Hz, NH), 5.00 (d, J1.2 3.66 Hz, H-1), 4.67 «r. J 7 Hz, MeCH), 4.75,
4.49 (2 d, 2 H, s.; 11.7 Hz, OCH2Ph), 4.61 (2 H, 6-0-CH2Ph), 4.48 (t, J 9.3 Hz,
H-4), 4.33 (ddd, J2.3 10.2 Hz, H-2), 3.82 (dd, J3.2 10.2, J3.4 9.2 Hz, H-3), 3.99-3.71 (m,
3 H, H-5, 6,6'), 1.97 (s, AcN), 1. 47 (d, J 7.08 Hz, MeCH.
An aL C2SH29N07(455.51) calc'd.: C 65.92 H 6.42; N 3.08%
found: C 66.09; H 6.29; N 3.14%
(b) From VIlI. - A suspension of the HO-6 free lactone VIlI (73 mg, 0.2 mmol),
freshly prepared silver carbonate (150 mg), benzyl bromide (120 mg, 0.7 mmol)
and molecular sieves (-300 mg) in dry benzene (12 ml) was stirred at room tempo
for 48 hrs. The precipitate was centrifuged off, washed with benzene, and the
combined supernatant and washings were concentrated. The residue was passed
through silica gel with solvent D (4: 1) to give chromatographically homogeneous
XVIII (35 mg, 38%); crystallisation from diisopropyl ether-acetone-light petroleum
afforded crystals indistinguishable (m. p., NMR) from those of XVIII prepared by
route (a). (Found: C 65.65; H 6.65; N 3.27%).
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Treatment of a sample (30 mg, 0.066 mmol) of XVIII in dry methanol (8 ml)
with silica gel (200 mg) for 2 hrs at room tempo led to complete conversion into
the methyl ester XVI (monitoring by TLC in solvent D, 4:1); removal of the
solvent and acetylation of the residue (AC20-Py 1: 2, 3 ml), followed by silica
gel chromatogprahy of the product, gave the 4-acetate XVII (25 mg) in 78% yield.
N-[2 -O-(B enzy 1 2-acetamido-6 -0- benzy 1-2,3-dideoxy-a- D-91ucopyranoside-3 -y 1)-
-(R)lactoy1]-L-a1anine mety1 est er (XIX)
6-0-Benzyl lactone XVIII (91.7 mg, 0.2 mmol) was treated with L-alanine
methyl ester [prepared from Boc-Ala-OMe (83 mg, 0.4 mmol) via trifluoroace-
tate salt] in the presence of imidazole (68 mg, 1 mmol) and THAB (21.3 mg,
0.04 mmole) in dry THF (total 10 ml) exactly as described for X. After 5 days
(monitoring of the reaction by TLC in solvent B), the solvent was evaporated
and the residue was chromatographed over a silica gel colum with solvent B to
give homogenous XIX (84 mg, 75.2%) which crystalltsed from hot diisopropyl
ether + some drops of acetone: m. p. 125-126° (softening at 122°C), [aD] + 90°.
lB:-NMR data: o 7.34, 7.33 (10 H, 2 Ph), 6.97 (d, J 8.79 Hz, NH), 6.10 (d, J 8.8 Hz,
NH), 4.92 (d, J1.2 3.66 Hz, H-1), 4.72, 4.45 (2 d, 2 H, s.: 11.7 Hz, O-CH2Ph), 4.60
(2 H, 6-0-CH2Ph), 3.70 (s, C02Me), 1.90 (s, AcN), 1.41, 1.40 (2 d, J 6.84 and 7.08
Hz, 2 MeCH).
AnaL C29HssN209 (558.61) calc'd.: C 62.35; H 6.86; N 5.01°1u
found: C 62.22; H 6.82; N 4.98%
N-[2-0-( Benzy 1 2-acetamido-4-0-acety 1-6-0- benzy 1-2,3-dideoxy-a- D-
-glucopyranoside-3-y1)-(R)-lactoy1]-L-a1anine methy1 ester (XX)
A sample (77 mg, 0.14 mmol) of XIX was treated with AC20-Py (2:1, 3 ml)
at room tempo overnight. After work-np, the residue was crystallised from diiso-
propyl ether-acetone to give the 4-acetate XX (66 mg, 80%) as shiny need les ;
m. p. 146-148°C (softening at 138°C), [ah + 95°. lH-NMR data: o 7.33 (10 H,
2 Ph), 6.88 (d, J 6.5 Hz, NH), 5.88 (d, J 10 Hz, NH), 5.05 (dd, J4.3 9.7, J4.5 10.0 Hz,
H-4), 4.88 (d, J1.2 3.52 Hz, H-1), 4.53 (2 H, 6-0-CH2Ph), 3.70 (s, C02Me), 3.54-3.45
(m, 2 H, H-6,6'), 1.971, 1.876 (2 s, AcO, AcN), 1.44 and 1.31 (2 d, J 7.32 and 6.74 Hz,
2 MeCH).
AnaL C31H40N2010(600.67) calc'd.: C 61.99; H 6.71; N 4.66%
found: C 62.20; H 6.96; N 4.56%
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SAZETAK
Aminoliza Iaktona N-acetiImuraminske kiseline s esterima aminokiselina peptiđa.
Sintetski put do derivata N-acetiImuramoiIamida
Dina Keglević, Mario Pongračić i Darko Kantoci
Ispitivana je reakcija aminolize HO-6-supstituiranih laktona N-acetilmuramin-
ske kiseline (MurNAc) s esterima aminokiselina i peptida kao nukleofilnom kom-
ponentom. Zaštićeni, (1-+ 6) povezani disaharid GlcNAc-MurNAc lakton I reagirao
je s L-alanin-metilesterom dajući odgovarajući disaharidamid VI čija je struktura
potvrđena i alternativnom sintezom. Reakcije benzilglikozida HO-6 acetiliranog,
benziliranog, odnosno tritiliranog MurNAc laktona (IX. XI, XVIII) s Ala-OMe i
Ala-Gly-OMe ispitivane su pod različitim uvjetima; utvrđeno je da prisutnost irni-
dazola i tetraheksilamonijbenzoata, kao i priroda otapala, bitno utječu na iskori-
štenja u kojima nastaju odgovarajući muramoilamidi (X, XII, XIII, XIX). Pruženi
su dokazi da otvaranje laktonskog prstena teče bez epimerizacije na položaju C-4,
tj. uz zadržavanje D-gluko-konfiguracije.
